Bandaram Pharma Packtech Ltd

Bandaram Pharma Packtech Limited has announced the submission of its Notice of Annual General Meeting (AGM) and Annual Report for the Financial Year 2025-26. The AGM, originally scheduled for September 18, 2026, has been postponed and rescheduled to Thursday, September 24, 2026, at 11:00 AM IST. The meeting will be conducted via Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The Board of Directors approved this postponement through a Circular Resolution. The cut-off date for determining voting rights is September 17, 2026. The filing also lists the Board of Directors, key management personnel, registered office details, bankers, and committees.

Bandaram Pharma Packtech Ltd has announced the postponement and rescheduling of its Annual General Meeting (AGM) for the Financial Year 2025-26. The AGM was initially planned for September 18, 2026, but has been moved to Thursday, September 24, 2026, at 11:00 AM IST. The meeting will be conducted via Video Conferencing (VC) or Other Audio-Visual Means (OAVM). The decision to postpone was made due to certain circumstances and approved by the Board via a Circular Resolution. The cut-off date for determining eligibility to attend the AGM is September 17, 2026. The company has also submitted its Annual Report for FY 2025-26 along with the AGM notice.

Bandaram Pharma Packtech Limited announced its un-audited financial results for the quarter ended June 30, 2026. The Board of Directors also approved the re-appointment of Mr. Suryaprakasa Rao Bommisetti as an Independent Director for a second term of 5 years and M/s. M.M. Reddy & Co. as statutory auditors for three years. The Annual General Meeting for FY 2025-26 is scheduled for September 18, 2026.

Bandaram Pharma Packtech Limited held a Board of Directors meeting on August 13, 2026. Key decisions included the re-appointment of Mr. Suryaprakasa Rao Bommisetti as an Independent Director for a second five-year term starting March 7, 2027, subject to member approval. Additionally, M/s. M.M. Reddy & Co. were re-appointed as statutory auditors for a three-year term from the conclusion of the upcoming AGM until the AGM for FY 2028-29, also pending member approval. The board also considered un-audited financial results for the quarter ended June 30, 2026, and approved the Director's Report for FY 2025-26. The Annual General Meeting for FY 2025-26 is scheduled for September 18, 2026, to be held via Video Conference/OAVM.

Bandaram Pharma Packtech Ltd has announced that its Board of Directors will convene on August 13, 2026. The primary agenda is to consider and approve the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026, along with the limited review report. Additionally, the board will discuss any other business with the Chair's permission. The company has also informed that the trading window for dealing in its securities is closed from July 1, 2026, until 48 hours after the declaration of these financial results, in compliance with SEBI regulations.

Bandaram Pharma Packtech Ltd has issued a clarification regarding recent price movements in its shares. The company stated that there are no significant events or price-sensitive information that could explain the increase in its stock price. This clarification is in response to a query from the exchange, referencing Regulation 30 of SEBI (LODR) Regulations, 2015. The company assures that any future material events impacting operations or share price will be promptly intimated to the exchange.

Bandaram Pharma Packtech Limited has announced the closure of its trading window for all designated persons, their immediate relatives, and connected persons. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from July 1, 2026, until 48 hours after the declaration of the standalone and consolidated unaudited financial results for the quarter ending June 30, 2026. A board meeting will be convened to consider and approve these financial results. The company will separately inform the stock exchange about the board meeting notice.

Bandaram Pharma Packtech Ltd has issued a clarification regarding a work order received by its material subsidiary, VSR Paper and Packaging Limited. The initial disclosure mistakenly stated the order value as Rs. 37.44 crore. The company has corrected this to Rs. 27.70 crore, representing two orders from the Government of Telangana for printing and distribution of textbooks for the academic year 2026-27. The execution period for these orders is June-August 2026.

Bandaram Pharma Packtech Ltd announced the resignation of Mr. NSK Aakarsh Raj as Whole-Time Director, effective June 5, 2026. The resignation is due to other professional and personal reasons, with no material undisclosed reasons cited. The company has provided the necessary disclosures as per SEBI regulations.

Bandaram Pharma Packtech's material subsidiary, VSR Paper and Packaging Limited, has received an order from M/s S. A. Printers for supplying raw materials for printing textbooks. The order, valued at ₹3,86,85,410, involves supplying paper, board, and other materials for printing and distributing textbooks for the academic year 2026-27. The order execution period is from June to August 2026.